ArticleBioinformation2025

Assessment of cardiovascular event reduction with SGLT2 inhibitors compared to GLP-1 receptor agonists in type 2 diabetes mellitus.

Vijaya Krishna Prasad Vudathaneni et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.